Nanion Corporate Blog


11.05.2021: Research Ins]i[ghts: Cardiac Safety Symposium 2021 - Session 2

Session 2 - Investigating Cardiac Physiology (the second of four sessions across our two-day event)

Selected Publications:

2020 - Integration of mechanical conditioning into a high throughput contractility assay for cardiac safety assessment

2018 - Cross-site comparison of excitation-contraction coupling using impedance and field potential recordings in hiPSC cardiomyocytes

2017 - Correlation between human ether-a-go-go related gene channel inhibition and action potential prolongation

The Cell Monitoring Brochure

Bettina Lickiss
Marketing & Scientific Communications Manager, innoVitro GmbH
Title: Advanced cardiac contractility assessment with integrated mechanical and optical stimulation of human iPSC-derived cardiomyocytes
[2:45 PM - 3:10 PM CEST]

Khuram Chaudhary
PhD, Scientific Director, GlaxoSmithKline
Title: In vitro cardiac safety pharmacology- considerations beyond hERG
[3:10 PM - 3:35 PM CEST]

Ravi Vaidyanathan
PhD, Product Manager - Cardiac - FUJIFILM Cellular Dynamics, Inc.
Title: Predictive and Physiologically Relevant 3D Tri-culture Cardiac Microtissue with iCell® Cardiomyocytes, Endothelial Cells and Primary Cardiac Fibroblast
[3:35 PM - 3:45 PM CEST]

Steve Jenkinson
PhD, Director of In Vitro Pharmacology, Pfizer Inc.
Title: The use of stem cell cardiomyocyte models in predicting clinical cardiac endpoints
[3:45 PM - 4:10 PM CEST]

Jin Chang
BD & Alliance Manager, NEXEL Co. Ltd
Title: Challenging our understanding of iPSC-based cardiac safety with physiologically relevant and assay-ready cell culture media
[4:10 PM - 4:20 PM CEST]

[4:20 PM - 4:40 PM CEST]

Register for the Event

Back to Overview


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.